Interferon Alfa-2b Adjuvant Therapy of High-Risk Resected Cutaneous Melanoma: The Eastern Cooperative Oncology Group Trial EST 1684.

Kirkwood, J M; Strawderman, M H; Ernstoff, M S; Smith, T J; Borden, E C; Blum, R H

Kirkwood, J M; Strawderman, M H; Ernstoff, M S; Smith, T J; Borden, E C; Blum, R H.

Afiliación

Kirkwood JM; Division of Medical Oncology, University of Pittsburgh, PA 15213-2582, USA.
Strawderman MH; Division of Medical Oncology, University of Pittsburgh, PA 15213-2582, USA.
Ernstoff MS; Division of Medical Oncology, University of Pittsburgh, PA 15213-2582, USA.
Smith TJ; Division of Medical Oncology, University of Pittsburgh, PA 15213-2582, USA.
Borden EC; Division of Medical Oncology, University of Pittsburgh, PA 15213-2582, USA.
Blum RH; Division of Medical Oncology, University of Pittsburgh, PA 15213-2582, USA.

J Clin Oncol ; 41(3): 425-435, 2023 01 20.

Article en En | MEDLINE | ID: mdl-36649675

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Idioma: En Revista: J Clin Oncol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google